| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5927659 | American Heart Journal | 2016 | 23 Pages |
Abstract
Prolonged DAPT after MI reduces MACE and cardiovascular mortality over the long term; this was paralleled by higher risk of nonfatal major bleeding mainly with the newer, more potent P2Y12 antagonists. Tailoring duration of DAPT after MI on the comparative evaluation of both ischemic and bleeding risk is mandatory in this setting.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Giuseppe MD, Ilaria MD,